share_log

Intuitive Surgical Stock Pops On Q3 Earnings Beat, Da Vinci Procedures Climb 18%, Regulatory Clearance Update And More

Intuitive Surgical Stock Pops On Q3 Earnings Beat, Da Vinci Procedures Climb 18%, Regulatory Clearance Update And More

直覺外科公司股票在第三季度盈利超預期後大漲,達芬奇手術數量增長18%,監管審批更新等等
Benzinga ·  10/18 04:27

Intuitive Surgical, Inc. (NASDAQ:ISRG) reported third-quarter financial results after markets closed on Thursday. Here's a rundown of everything you need to know.

納斯達克股票代碼ISRG的直覺外科公司在週四收盤後發佈了第三季度財務業績。以下是您需要了解的一切。

Q3 Earnings Top Estimates: Intuitive Surgical reported third-quarter revenue of $2.04 billion, beating the consensus estimate of $2 billion. The robotic-assisted surgery company reported third-quarter adjusted earnings of $1.84 per share, beating analyst estimates of $1.63 per share, according to Benzinga Pro.

Q3盈利超出預期:直覺外科公司報告第三季度營業收入爲20.4億美元,超過了20億美元的共識預期。根據彭博社,這家機器人輔助手術公司報告第三季度調整後每股收益爲1.84美元,超過了分析師預期的1.63美元。

Revenue climbed 17% on a year-over-year basis. Worldwide da Vinci procedures increased approximately 18% year-over-year. The company said it placed 379 da Vinci surgical systems in the quarter, versus 312 in the prior year's quarter; 110 of the systems placed during the quarter were Intuitive's da Vinci 5 systems.

營業收入同比增長17%。全球da Vinci程序同比增長約18%。公司表示,本季度共放置了379台da Vinci外科系統,而去年同期爲312台;本季度放置的系統中,有110台是直覺的da Vinci 5系統。

Intuitive Surgical's da Vinci surgical system installed base totaled 9,539 systems as of Sept. 30, up 15% year-over-year. The company ended the quarter with $8.31 billion in cash, cash equivalents and investments, up $628 million during the quarter.

直覺外科的da Vinci外科系統安裝基數在截至9月30日時達到了9539系統,同比增長15%。該公司在本季度結束時的現金、現金等價物和投資達到了83.1億美元,較本季度增加了62800萬美元。

"Core measures of our business were healthy this quarter, and we are pleased by customer adoption of da Vinci 5," said Gary Guthart, CEO of Intuitive Surgical. "We remain focused on delivering the goals we share with our customers, centered on improving patient outcomes."

"本季度我們業務的核心指標表現良好,我們對客戶對da Vinci 5的採用感到滿意,"直覺外科公司的CEO加里·古塔特說。"我們繼續專注於實現與客戶共享的目標,重點是改善患者預後。"

Intuitive Surgical said it obtained regulatory clearance in South Korea for the da Vinci 5 surgical system in October. The company's latest surgical systems can now be used in urologic, general, gynecologic, thoracoscopic, thoracoscopically-assisted cardiotomy and transoral otolaryngology surgical procedures.

直覺外科表示,該公司於10月獲得了在韓國使用da Vinci 5外科系統的監管批准。該公司最新的外科系統現在可以用於泌尿科、普通外科、婦科、胸腔鏡手術、胸腔輔助心切開術和經口腔喉科手術。

Intuitive Surgical scheduled a conference call to discuss the company's quarterly performance with analysts and investors at 4:30 p.m. ET.

直覺外科安排了一個電話會議,與分析師和投資者一起討論公司的季度表現,時間是Et下午4:30。

ISRG Price Action: Intuitive Surgical shares were up 6.39% in after-hours, trading at $505 at the time of publication Thursday, according to Benzinga Pro.

ISRG股價表現:根據彭博社,直覺外科股價在週四發佈時的交易時間晚間上漲了6.39%,報505美元。

  • Abbott Labs Path To Double-Digit Earnings Growth In 2025? This Analyst Is Optimistic

  • Abbott Labs在2025年實現兩位數盈利增長的路徑?這位分析師持樂觀態度

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論